Baxter: Tests show suspect heparin was pure

Baxter International has determined that quality issues weren't involved in the deaths of two patients who took the company's heparin products. An array of forensic and analytical tests verify the heparin products were pure and didn't contain any contaminants, Baxter said. Report

Suggested Articles

J&J's talc woes deepened Friday after the FDA turned up "sub-trace" levels of asbestos one bottle of the company's baby powder,…

Another major drugmaker is recalling in the U.K. 10 batches of its Zantac generics because they contain a possible carcinogen.

With diagnosis rates on the rise, Pfizer's Vyndaqel franchise could collect $157 million in 2019 U.S. sales, well above consensus, SVB Leerink says.